Bio-Works Technologies AB (publ) (NGM: BIOWKS)

Market Cap	73.27M
Revenue (ttm)	37.88M
Net Income (ttm)	-37.52M
Shares Out	77.96M
EPS (ttm)	-0.94
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	416
Average Volume	37,989
Open	0.960
Previous Close	0.940
Day's Range	0.960 - 0.960
52-Week Range	0.720 - 8.400
Beta	1.16
RSI	54.04
Earnings Date	Feb 21, 2025

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography r...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 36
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: BIOWKS

Financial Performance

In 2023, Bio-Works Technologies AB's revenue was 43.90 million, an increase of 6.23% compared to the previous year's 41.32 million. Losses were -56.82 million, 26.4% more than in 2022.